Linked Life Data

14702922

Source:http://linkedlifedata.com/resource/pubmed/id/14702922

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
46
pubmed:dateCreated
2004-1-1
pubmed:abstractText
Positron emission tomography (PET) is a useful tool for the investigation of certain physiological changes and for the evaluation of the distribution, and receptor binding of drugs labelled with positron emitting isotopes. Vinpocetine (ethyl-apovincaminate) is a neuroprotective drug widely used in the prevention and treatment of cerebrovascular diseases. In the clinical practice vinpocetine is usually administered to the patients in intravenous infusion followed by long-term oral treatment. Until presently human data describing vinpocetine's kinetics and brain distribution came from ex vivo (blood, plasma, liquor) and post mortem (brain autoradiography) measurements.
pubmed:language
hun
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0030-6002
pubmed:author
pubmed:issnType
Print
pubmed:day
16
pubmed:volume
144
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2271-6
pubmed:dateRevised
2009-10-21
pubmed:meshHeading
pubmed:year
2003
pubmed:articleTitle
[Human positron emission tomography with oral 11C-vinpocetine].
pubmed:affiliation
Department of Clinical Neuroscience, Psychiatry Section, Karolinska Institute, Stockholm.
pubmed:publicationType
Journal Article, Clinical Trial, English Abstract